<p>Deltamethrin (a pyrethroid) and acetamiprid (a neonicotinoid) are widely used insecticides that have raised increasing concerns due to their potential toxicity. This study aimed to investigate their cytotoxic, morphological and molecular effects on normal (Thle-2) and cancerous (HepG2) human liver cell lines, as well as their interactions with key antioxidant-related enzymes. IC<sub>50</sub> values were determined using XTT assay following 24- and 48 h exposures to each compound individually and in combination. Cell motility was evaluated using wound healing assays, while oxidative stress-related gene expressions (<i>CAT</i>, <i>SOD1</i>, <i>GSTK1</i>) were analysed by qRT-PCR.</p><p>In Thle-2 cells, <i>CAT</i> and <i>GSTK1</i> expression significantly decreased after acetamiprid exposure (p &lt; 0.05). In HepG2 cells, <i>GSTK1</i> expression decreased with individual treatments but increased significantly under combined exposure compared to deltamethrin alone (p &lt; 0.05). Moelcular docking analysis revealed that deltamethrin exhibited stronger binding affinities with antioxidant ezymes, particularly SOD1 (−8.1 kcal/mol) and CAT (−8.0 kcal/mol), suggesting a higher potential for enzyme inhibition. In contrast, acetamiprid showed moderate affinities, with the lowest energy for CAT (−6.8 kcal/mol). ProTox predictions indicated moderate hepatotoxic, neurotoxic, and respiratory toxic potentials for deltamethrin, whereas acetamiprdi displayed a generally loe toxicity profile. Overall, these results suggest that both compunds modulate antioxidant defense mechanism and induce oxidative stress responses, with differential toxicity between normal and cancerous liver cells.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Comparative cytotoxic and molecular effects of deltamethrin and acetamiprid in normal and cancerous human liver cell lines

  • Cansu Aydın,
  • Selin Özkan-Kotiloğlu,
  • Serap Yalçın-Azarkan

摘要

Deltamethrin (a pyrethroid) and acetamiprid (a neonicotinoid) are widely used insecticides that have raised increasing concerns due to their potential toxicity. This study aimed to investigate their cytotoxic, morphological and molecular effects on normal (Thle-2) and cancerous (HepG2) human liver cell lines, as well as their interactions with key antioxidant-related enzymes. IC50 values were determined using XTT assay following 24- and 48 h exposures to each compound individually and in combination. Cell motility was evaluated using wound healing assays, while oxidative stress-related gene expressions (CAT, SOD1, GSTK1) were analysed by qRT-PCR.

In Thle-2 cells, CAT and GSTK1 expression significantly decreased after acetamiprid exposure (p < 0.05). In HepG2 cells, GSTK1 expression decreased with individual treatments but increased significantly under combined exposure compared to deltamethrin alone (p < 0.05). Moelcular docking analysis revealed that deltamethrin exhibited stronger binding affinities with antioxidant ezymes, particularly SOD1 (−8.1 kcal/mol) and CAT (−8.0 kcal/mol), suggesting a higher potential for enzyme inhibition. In contrast, acetamiprid showed moderate affinities, with the lowest energy for CAT (−6.8 kcal/mol). ProTox predictions indicated moderate hepatotoxic, neurotoxic, and respiratory toxic potentials for deltamethrin, whereas acetamiprdi displayed a generally loe toxicity profile. Overall, these results suggest that both compunds modulate antioxidant defense mechanism and induce oxidative stress responses, with differential toxicity between normal and cancerous liver cells.